Suven Life secures patents for CNS drug in Israel, Macau and US – Business Standard

June 17 07:40 2015

Suven Life Sciences Ltd has received product patents for new chemical entities (NCEs) – used in the treatment of disorders associated with neurodegenerative diseases – from Israel, Macau and USA. The granted claims of the patents include the class of …

Read Full Story On business-standard.com

  Categories: